United States

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

CareDX, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

14167L103

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☐ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 14167L103

 

 1.   

 Names of Reporting Persons

 

 Bellevue Asset Management (UK) Ltd.

 2.  

 Check the Appropriate Box if a Member of a Group (See Instructions)

 (a) ☒  (b) ☐

 

 3.  

 SEC Use Only

 

 4.  

 Citizenship or Place of Organization

 

 England and Wales

Number of

Shares  Beneficially 

Owned by

Each

Reporting

Person

with:

   5.   

 Sole Voting Power

 

 0

   6.  

 Shared Voting Power

 

 3,954,792

   7.  

 Sole Dispositive Power

 

 0

   8.  

 Shared Dispositive Power

 

 3,954,792

 9.   

 Aggregate Amount Beneficially Owned by Each Reporting Person

 

 3,954,792

10.  

 Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

 ☐

11.  

 Percent of Class Represented by amount in Row (9)

 

 7.3%

12.  

 Type of Reporting Person (See Instructions)

 

 FI

 

2


CUSIP No. 14167L103

 

 1.   

 Names of Reporting Persons

 

 Bellevue Group AG

 2.  

 Check the Appropriate Box if a Member of a Group (See Instructions)

 (a) ☒  (b) ☐

 

 3.  

 SEC Use Only

 

 4.  

 Citizenship or Place of Organization

 

 Switzerland

Number of

Shares  Beneficially 

Owned by

Each

Reporting

Person

with:

   5.   

 Sole Voting Power

 

 0

   6.  

 Shared Voting Power

 

 3,954,792

   7.  

 Sole Dispositive Power

 

 0

   8.  

 Shared Dispositive Power

 

 3,954,792

 9.   

 Aggregate Amount Beneficially Owned by Each Reporting Person

 

 3,954,792

10.  

 Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

 ☐

11.  

 Percent of Class Represented by amount in Row (9)

 

 7.3%

12.  

 Type of Reporting Person (See Instructions)

 

 CO, HC

 

 

3


Item 1

1(a) Name of Issuer: CareDX, Inc.

1(b) Address of Issuer’s Principal Executive Offices:

3260 Bayshore Boulevard, Brisbane, CA 94005

Item 2

2(a) Name of Person Filing: Bellevue Group AG (“Bellevue Group”) on behalf of its wholly-owned subsidiary, Bellevue Asset Management (UK) Ltd. (“Bellevue Asset Management”).

2(b) Address of Principal Business Office or, if none, Residence:

Bellevue Asset Management (UK) Ltd.: 32 London Bridge Street, 24th Floor, London, England SE1 9SG

Bellevue Group AG:  Seestrasse 16, Kuesnacht, Switzerland, CH-8700

2(c) Citizenship: Bellevue Asset Management (UK) Ltd.: England and Wales

Bellevue Group AG: Switzerland

2(d) Title of Class of Securities: Common Stock

2(e) CUSIP Number: 14167L103

Item 4. Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a)

Amount beneficially owned: 3,954,792

 

  (b)

Percent of class: 7.3%

 

  (c)

Number of shares as to which the person has:

 

  (i)

Sole power to vote or to direct the vote 0

 

  (ii)

Shared power to vote or to direct the vote 3,954,792

 

  (iii)

Sole power to dispose or to direct the disposition of 0

 

  (iv)

Shared power to dispose or to direct the disposition of 3,954,792

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

This statement is filed jointly by Bellevue Asset Management and Bellevue Group. Bellevue Asset Management is a wholly-owned subsidiary of Bellevue Group.

 

4


Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

By signing below I also certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to investment advisers and investment companies is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURES

After reasonable inquiry and the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Bellevue Asset Management (UK) Ltd.    
Date: February 12, 2024     By:  

/s/ Martin Gubler

      Signatory Authority
    Name:   Martin Gubler
    Title:   Director
Bellevue Group AG    
Date: February 12, 2024     By:  

/s/ Michael Hutter

      Signatory Authority
    Name:   Michael Hutter
    Title:   Chief Financial Officer
Date: February 12, 2024     By:  

/s/ Christoph Eisenring

      Signatory Authority
    Name:   Christoph Eisenring
    Title:   Head Legal & Compliance

 

5


Exhibit Index

Exhibit A: Agreement by and between Bellevue Asset Management (UK) Ltd. and Bellevue Group AG with respect to the filing of this disclosure statement.*

 

*

Previously filed as an exhibit to Bellevue Asset Management (UK) Ltd. and Bellevue Group AG’s Schedule 13G filed with the Securities and Exchange Commission on February 14, 2023.

 

6


CareDx (NASDAQ:CDNA)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more CareDx Charts.
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more CareDx Charts.